Ownership history in STRS OHIO · 11 quarters on record
This page tracks every 13F SEC filing in which STRS OHIO reported a position in ENTRADA THERAPEUTICS INC (TRDA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 3,800 | -41,200 | -91.6% | 0.00% | $22K | $5.80 |
| 2025 Q2 | ADDED | 45,000 | +3,200 | +7.7% | 0.00% | $302K | $6.72 |
| 2025 Q1 | ADDED | 41,800 | +3,300 | +8.6% | 0.00% | $378K | $9.04 |
| 2024 Q3 | ADDED | 38,500 | +9,900 | +34.6% | 0.00% | $615K | $15.98 |
| 2024 Q2 | ADDED | 28,600 | +2,900 | +11.3% | 0.00% | $408K | $14.25 |
| 2024 Q1 | ADDED | 25,700 | +1,600 | +6.6% | 0.00% | $364K | $14.17 |
| 2023 Q4 | ADDED | 24,100 | +21,400 | +792.6% | 0.00% | $363K | $15.09 |
| 2023 Q3 | UNCHANGED | 2,700 | — | 0% | 0.00% | $42K | $15.80 |
| 2023 Q2 | ADDED | 2,700 | +600 | +28.6% | 0.00% | $40K | $15.14 |
| 2022 Q1 | UNCHANGED | 2,100 | — | 0% | 0.00% | $19K | $9.39 |
As of 2025 Q4 — sorted by position size